Critical

Massive intraoperative haemorrhage

Major haemorrhage protocol · Perioperative & Anaesthesia
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Life-threatening surgical bleeding requiring activation of the major haemorrhage protocol, rapid transfusion and damage-control resuscitation. Goals are haemorrhage control, maintenance of oxygen delivery and correction of the coagulopathy, acidosis and hypothermia that worsen bleeding.

Red flags

  • Ongoing uncontrolled bleeding despite surgical attempts
  • Developing coagulopathic ooze from all surfaces
  • Hypotension unresponsive to transfusion
  • Rising lactate / worsening base deficit
  • Hypocalcaemia, hyperkalaemia or hypothermia from massive transfusion
  • Cardiac arrest from exsanguination

Assessment

Differential diagnosis

  • Surgical bleeding (vascular injury, raw surface, failed haemostasis)
  • Dilutional/consumptive coagulopathy
  • Pre-existing coagulopathy or antithrombotic drugs
  • Hyperfibrinolysis
  • Hypothermia- and acidosis-related coagulopathy
  • Hypocalcaemia from citrate (transfusion)

Investigations

  • Serial haemoglobin / point-of-care haematocrit
  • Coagulation screen, fibrinogen, platelets
  • Viscoelastic testing (ROTEM/TEG) to guide products
  • ABG with lactate, base deficit, ionised calcium and potassium
  • Temperature monitoring
  • Group and crossmatch / immediate issue of emergency blood

Management

  • Declare a major haemorrhage and activate the hospital major haemorrhage protocol; call for senior help and extra hands
  • Alert the blood bank and assign a team member to coordinate products and communication
  • Apply direct pressure/surgical control; consider proximal control, packing, aortic compression or tourniquet
  • Secure large-bore IV/IO access and use a rapid infuser with fluid/blood warmer
  • Transfuse red cells early; give balanced blood products (RBC:FFP:platelets in a fixed ratio) until guided by lab/viscoelastic results
  • Give tranexamic acid early
  • Monitor and replace ionised calcium; keep it normal
  • Maintain normothermia with active warming and warmed fluids
  • Correct acidosis and avoid excessive crystalloid (permissive hypotension until surgical control where appropriate)
  • Use viscoelastic testing to target fibrinogen, platelets and clotting factors
  • Consider cell salvage where appropriate
  • Stand down the protocol when bleeding controlled and document

Drugs & doses

Tranexamic acid 1 g IV over 10 min then 1 g over 8 h (give within 3 h)
Packed red cells, FFP and platelets in ~1:1:1 ratio initially
Fibrinogen (cryoprecipitate 2 pools or fibrinogen concentrate) to keep fibrinogen >1.5 g/L (>2 in obstetric)
Calcium chloride 10% 10 mL IV (or gluconate) to maintain ionised calcium >1.0 mmol/L
Prothrombin complex concentrate for warfarin-related bleeding (with vitamin K)
Vasopressors (noradrenaline/metaraminol) as a bridge while volume is restored

Disposition

Achieve haemostasis then transfer to critical care for ongoing resuscitation, correction of coagulopathy and monitoring; involve haematology, interventional radiology and surgical seniors throughout.

Complications & pitfalls

  • Hypoperfusion and multi-organ failure
  • Dilutional coagulopathy and DIC
  • Transfusion reactions, TACO/TRALI
  • Citrate toxicity/hypocalcaemia and hyperkalaemia
  • Hypothermia and acidosis (lethal triad)
  • Cardiac arrest and death

Exam pearls

  • Stop the bleeding and resuscitate in parallel; definitive surgical/radiological control is the priority
  • Give blood products in balanced ratios and switch to goal-directed replacement with viscoelastic testing
  • Give tranexamic acid early; it reduces mortality when given within 3 hours
  • Monitor and replace ionised calcium; massive transfusion causes citrate-induced hypocalcaemia
  • Prevent the lethal triad: keep the patient warm, correct acidosis, avoid dilution

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.